Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types

Cécile Chartier(Io Therapeutics (United States)), Austin Gurney(Australian Centre for Heart Health), Wan-Ching Yen(OncoMed (United States)), Marcus Fischer(St. Jude Children's Research Hospital), Michelle Stroud(OncoMed (United States)), Janak Raval(OncoMed (United States)), Cristina Dee-Hoskins, Gilbert O’Young(OncoMed (United States)), Jennifer Cain(Gilead Sciences (United States)), Fumiko Axelrod(OncoMed (United States)), May Ji(OncoMed (United States)), Belinda Cancilla(OncoMed (United States)), Pete Yeung(OncoMed (United States)), Ann M. Kapoun(OncoMed (United States)), Chris Bond(OncoMed (United States)), Shirley Ma(University of Maryland Center for Environmental Science), Timothy Hoey, Min Wang(Central South University), Jalpa Shah(OncoMed (United States)), Andrew Lam(OncoMed (United States)), Jie Wei(OncoMed (United States)), John Lewicki(OncoMed (United States))
Cancer Research
January 11, 2016
Cited by 115


Related Papers